1. Home
  2. PASG vs MODD Comparison

PASG vs MODD Comparison

Compare PASG & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PASG

Passage Bio Inc.

HOLD

Current Price

$5.20

Market Cap

26.0M

Sector

Health Care

ML Signal

HOLD

Logo Modular Medical Inc.

MODD

Modular Medical Inc.

HOLD

Current Price

$4.39

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PASG
MODD
Founded
2017
1998
Country
United States
United States
Employees
27
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
23.5M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
PASG
MODD
Price
$5.20
$4.39
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
64.6K
18.4K
Earning Date
05-12-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.62
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$0.12
52 Week High
$20.00
$6.16

Technical Indicators

Market Signals
Indicator
PASG
MODD
Relative Strength Index (RSI) 42.65 59.08
Support Level $3.94 $0.41
Resistance Level $5.74 $6.04
Average True Range (ATR) 0.38 0.43
MACD 0.18 -0.01
Stochastic Oscillator 69.53 87.94

Price Performance

Historical Comparison
PASG
MODD

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

About MODD Modular Medical Inc.

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

Share on Social Networks: